TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients

Table 3

Correlations of the serum levels of HMGB1 with percentage of CD14⁺ TREM-1⁺, CD14⁺ TREM-2⁺ monocytes, and TREM-1/TREM-2 ratio.

HMGB1 (all gliomas)				95% CI
	CD14^+ TREM-1^+ Mo	Spearman	-0.272
			0.049	-0.512 to 0.006
	CD14^+ TREM-2^+ Mo	Spearman	0.369
			0.007	0.102 to 0.587
	TREM-1/TREM-2 ratio	Spearman	-0.398
			0.004	-0.611 to -0.132
HMGB1 (G. IV)
	CD14^+ TREM-1^+ Mo	Spearman	-0.479
			0.016	-0.741 to -0.091
	CD14^+ TREM-2^+ Mo	Spearman	0.363
			0.075	-0.050 to 0.670
	TREM-1/TREM-2 ratio	Spearman	-0.516
			0.008	-0.762 to -0.140

GBM: glioblastoma multiforme.